Eppin Pharma

About Eppin Pharma

Eppin Pharma Inc., based in Chapel Hill, North Carolina, is an emerging pharmaceutical company dedicated to developing a safe, effective, short-term, non-hormonal oral male contraceptive pill. Their mission is to prevent pregnancies with no side effects and revolutionize family planning by equalizing the burden of contraception and extending secure family planning options.

Products & Services

Non-Hormonal Male Contraceptive Pill:A small organic compound that binds to EPPIN, a protein on human sperm, resulting in loss of sperm motility. This fast-acting, non-hormonal treatment does not affect sperm production and aims to be easy to use with no side effects.

Specialties

Non-Hormonal Male Contraception Family Planning Solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Program Related Investment (PRI) T: - FT: Program Related Investment (PRI)	A: 800000 MR: - FA: up to $800,000 FAN: 800000	D: 2023-01-19 FD: 2023-01-19	1 investors

Program Related Investment (PRI) Latest

2023-01-19

$800K

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Michael G. O'Rand

President & Chief Executive Officer

K

Katherine G. Hamil

Senior Director of Operations

J

Jeffrey A Handler

Board certified toxicologist

Z

Zahed Subhan

Executive Chairman of the Eppin Pharma Inc Board of Directors

L

Laneta Dorflinger

Distinguished Scientist and Director, Contraceptive Technology Innovation, FHI360

J

John K. Amory

Professor of Medicine, Section Head, General Internal Medicine

View 3 more team members with Pro

Unlock Full Team Directory

Recent News

Eppin Pharma Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised